Significance of enhanced expression of nitric oxide syntheses in splenic sinus lining cells in altered portal hemodynamics of idiopathic portal hypertension

Digestive Diseases and Sciences

Volumn 52, Issue 8, 2007, Pages 1987-1994

  Sato, Yasunori ^a   Sawada, Seiko ^a   Kozaka, Kazuto ^a   Harada, Kenichi ^a   Sasaki, Motoko ^a   Matsui, Osamu ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Endothelin; Idiopathic portal hypertension; Nitric oxide; Spleen

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MONONUCLEAR CELL; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SPLENOMEGALY; STAINING;

AGED; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION, PORTAL; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PORTAL SYSTEM; SPLEEN; SPLENOMEGALY;

EID: 34347379307     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9146-9     Document Type: Article

References (22)

1. Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K (2001) Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract 197:65-76
2. Nakanuma Y, Hoso M, Sasaki M, Terada T, Katayanagi K, Nonomura A, Kurumaya H, Harada A, Obata H (1996) Histopathology of the liver in noncirrhotic portal hypertension of unknown aetiology. Histopathology 28:195-204
3. Okudaira M, Ohbu M, Okuda K (2002) Idiopathic portal hypertension and its pathology. Semin Liver Dis 22:59-72
4. Okuda K, Kono K, Ohnishi K, et al. (1984) Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 86:600-610
5. Tsuneyama K, Ohba K, Zen Y, Sato Y, Niwa H, Minato H, Nakanuma Y (2003) A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology 43:55-61
6. Tsuneyama K, Kouda W, Nakanuma Y (2002) Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and immunochemical study. Pathol Res Pract 198:597-603
7. Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, Puri P, Mitra SK, Suri S (2002) Noncirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 17:6-16
8. Maesawa C, Sakuma T, Sato T, Masuda T, Muro-oka G, Satodate R (1995) Structural characteristic of splenic sinuses in idiopathic portal hypertension. Pathol Int 45:642-648
9. Akahoshi T, Hashizume M, Tanoue K, Shimabukuro R, Gotoh N, Tomikawa M, Sugimachi K (2002) Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol 17:59-65
10. Kaido T, Oe H, Yoshikawa A, Okajima A, Imamura M (2004) Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. Hepatogastroenterology 51:547-551
11. Rockey D (1997) The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 25:2-5
12. Wiest R, Groszmann RJ (1999) Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin Liver Dis 19:411-426
13. Farzaneh-Far R, Moore K (2001) Nitric oxide and the liver. Liver 21:161-174
14. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863-2867
15. Nagasue N, Dhar DK, Yamanoi A, Emi Y, Udagawa J, Yamamoto A, Tachibana M, Kubota H, Kohno H, Harada T (2000) Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis. Hepatology 31:1107-1114
16. Ohara N, Futagawa S, Watanabe S, Fukasawa M, Takamori S (2001) Clinical investigation of endothelin-1 and nitric oxide in patients with portal hypertension focusing on plasma levels and immunohistological staining of liver tissues. Hepatol Res 21:40-54
17. Yamamoto K (1978) Morphological studies of the spleen in splenomegalic liver cirrhosis comparing with the spleen in idiopathic portal hypertension (so-called Banti's syndrome without liver cirrhosis). Acta Pathol Jpn 28:891-905
18. Cavalli G, Re G, Casali AM, Monari P (1982) The microvascular architecture of spleen in congestive splenomegaly. A morphological-histometric study. Pathol Res Pract 174:131-146
19. Suzuki T (1972) Application of scanning electron microscopy in the study of the human spleen: three dimensional fine structure of the normal red pulp and its changes as seen in splenomegalias associated with Banti's syndrome and cirrhosis of the liver. Nippon Ketsueki Gakkai Zasshi 35:506-522
20. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012
21. Kamath PS, Carpenter HA, Lloyd RV, McKusick MA, Steers JL, Nagorney DM, Miller VM (2000) Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver. Liver Transpl 6:596-602
22. Blendis L, Wong F (2001) The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther 89:221-231